APA Alıntı

Liu, Y., Yue, C., Li, J., Wu, J., Wang, S., Sun, D., . . . Wang, R. (2018). Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cells. Oncol Lett.

Chicago Stili Alıntı

Liu, Yongqing, et al. "Enhancement of Cisplatin Cytotoxicity By Retigeric Acid B Involves Blocking DNA Repair and Activating DR5 in Prostate Cancer Cells." Oncol Lett 2018.

MLA Alıntı

Liu, Yongqing, et al. "Enhancement of Cisplatin Cytotoxicity By Retigeric Acid B Involves Blocking DNA Repair and Activating DR5 in Prostate Cancer Cells." Oncol Lett 2018.